Owlo is a spin-off company of the Institut Langevin (ESPCI Paris, CNRS) founded in October 2024. After more than ten years of research in the field of optical imaging, our patented technology makes it possible to push the current boundaries of microscopy and enables non-invasive, real-time 3D imaging deep within biological tissue. Owlo has applications in the fields of IVF, drug discovery and ophthalmology.
.jpg)
%20(2).jpg)
